Akeso (HKG:9926) said its PD-1/VEGF bispecific antibody ivonescimab demonstrated a statistically significant and clinically meaningful overall survival benefit versus pembrolizumab in an interim analysis of a Phase 3 trial, according to a Thursday Hong Kong bourse filing.
The HARMONi-2 study met its pre-specified key secondary endpoint of overall survival in patients with locally advanced or metastatic non-small cell lung cancer with positive PD-L1 expression, the company said.
Western Mining (SHA:601168) subsidiary Tibet Yulong Copper donated 10 million yuan for mudslide victims in Gyirong County in Tibet, according to a Wednesday filing with the Shanghai bourse.The donation will come from the subsidiary's own funds.Company shares fell 2% during the midday break on Wednesday.
Gunkul Engineering (SET:GUNKUL) has appointed Thitawat Asaves as the chief financial officer of the company with effect from Tuesday, according to a same-day filing to the Thai stock exchange.The renewable energy company's shares were down nearly 1% in Wednesday's trade.He takes over from acting CFO Naruechon Dhumrongpiyawut, who resigned from the position effective Aug. 31.
Viva Goods (HKG:0933) has purchased 29.6 million shares of Chinese sportswear giant Li Ning (HKG:2331) for HK$398.4 million as an investment, according to a Tuesday bourse filing.The company said it bought the shares through open market transactions at an average price of HK$13.45 apiece.Following the transaction, Viva's stakeholding in Li Ning rose to 16.9%, with ownership of 437.2 million shares.